MarkGimbelMD
General Surgery • Gilbert, AZColon & Rectal Surgery, Melanoma, Surgical Oncology (Other than Breast)
Banner MD Anderson Cancer Center
Dr. Gimbel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2946 E Banner Gateway Dr
Gilbert, AZ 85234Phone+1 480-256-6444Fax+1 480-256-4734
Education & Training
H. Lee Moffitt Cancer Center and Research InstituteFellowship, 2007 - 2009
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Surgery, 2004 - 2007
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2002 - 2004
University of Florida College of Medicine JacksonvilleResidency, Surgery, 2000 - 2002
University of Maryland School of MedicineClass of 2000
Certifications & Licensure
AZ State Medical License 2009 - 2026
FL State Medical License 2008 - 2010- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma Start of enrollment: 2019 Dec 17
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 2 citationsHigh GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition.Anngela C Adams, Elizabeth S Borden, Anne M Macy, Nick Thomson, Haiyan Cui
Cancers. 2022-04-28 - 32 citationsThrombotic Thrombocytopenic Purpura due to Checkpoint Inhibitors.Alexey Youssef, Nawara Kasso, Antonio Sergio Torloni, Michael Stanek, Tomislav Dragovich
Case Reports in Hematology. 2018-12-20 - 169 citationsMechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma.Sunilkumar Kakadia, Naveen Yarlagadda, Ramez Awad, Madappa N. Kundranda, Jiaxin Niu
Oncotargets and Therapy. 2018-10-17
Press Mentions
Health Care Heroes 2022: Physician Winner Dr. Suma RaoAugust 18th, 2022- Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, the George Washington University, and Integrity ResearchMarch 14th, 2024
Professional Memberships
- Member
- Connective Tissue Oncology SocietyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
